Post Chikungunya Arthritis: A Real Diagnostic and Therapeutic Challenge

Authors

  • Muhammad Ishaq Ghauri Jinnah Medical College Hospital
  • Mohammad Shariq Mukarram Jinnah Medical College Hospital
  • Ashok Kumar Jinnah Medical College Hospital
  • Amir Riaz Liaqat National Hospital
  • Syeda Urooj Riaz Jinnah Medical College Hospital
  • Mohammad Mashood Iqbal Jinnah Medical College Hospital

DOI:

https://doi.org/10.36570/jduhs.2020.1.890

Keywords:

Chikungunya (CHIK), Arthritis, Disease modifying anti rheumatic drugs (DMARDs), Non-steroidal Antiinflammatory, drugs (NSAIDs), Disease activity score 28 (DAS 28)

Abstract

Objective: To evaluate the response of disease modifying anti rheumatic drugs (DMARDs) on patients diagnosed with post chikungunya inflammatory arthritis attending outpatient department of Rheumatology, Jinnah Medical College Hospital, Karachi, Pakistan.

Methods: This prospective case series study was conducted at Rheumatology clinic of Jinnah Medical College Hospital in Karachi, Pakistan from January – June 2017 after a serious Chikungunya outbreak in November 2016. All patients diagnosed with Chikungunya viral fever who had joint pain refractory to non-steroidal anti-inflammatory drugs (NSAIDs) were evaluated. All eligible patients were given a trial of DMARDs along with systemic steroids (tapering) for 6 months. Clinical response and inflammatory burden were evaluated using the Disease Activity Score (DAS 28).

Results: Of 112 patients, more than half the population, 65/112 (58%) was in acute flare of disease at the beginning of study and interestingly not a single patient had high disease activity (DAS >5.1) at the end of 6 months. Patients who went into disease remission were able to lead a pain free life, while those with a relatively higher DAS28 were still struggling with the disease. The overall response to the therapy was eloquent. None of the patient remained in active flair by the end of 6 months. The mean DAS significantly decline at 6 months as compared to the baseline DAS (2.79 ±0.89 vs. 4.96 ±1.11 respectively, p-value <0.001)

Conclusion: Chikungunya virus can lead to symmetrical inflammatory arthritis that phenotypically mimics Rheumatoid arthritis but is not primarily Rheumatoid arthritis.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2020-04-27

How to Cite

Ghauri, M. I., Mukarram, M. S., Kumar, A., Riaz, A., Riaz, S. U., & Iqbal, M. M. (2020). Post Chikungunya Arthritis: A Real Diagnostic and Therapeutic Challenge. Journal of the Dow University of Health Sciences (JDUHS), 14(1), 22–26. https://doi.org/10.36570/jduhs.2020.1.890

Issue

Section

Original Articles